Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
The company has raised US$4.5 million in funding for its AI operating system
CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Subscribe To Our Newsletter & Stay Updated
